BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9694505)

  • 21. Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligand.
    Hong DS; Huss R; Beckham C; Hoy CA; Storb R; Deeg HJ
    Transplant Proc; 1995 Feb; 27(1):642-3. PubMed ID: 7533430
    [No Abstract]   [Full Text] [Related]  

  • 22. CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cells.
    Rovere P; Clementi E; Ferrarini M; Heltai S; Sciorati C; Sabbadini MG; Rugarli C; Manfredi AA
    J Immunol; 1996 Jun; 156(12):4631-7. PubMed ID: 8648106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantation.
    Egeland T; Tjønnfjord G; Steen R; Gaudernack G; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1261-3. PubMed ID: 7680152
    [No Abstract]   [Full Text] [Related]  

  • 24. Tie1, a receptor tyrosine kinase essential for vascular endothelial cell integrity, is not critical for the development of hematopoietic cells.
    Rodewald HR; Sato TN
    Oncogene; 1996 Jan; 12(2):397-404. PubMed ID: 8570217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95).
    Takenaka K; Nagafuji K; Harada M; Mizuno S; Miyamoto T; Makino S; Gondo H; Okamura T; Niho Y
    Blood; 1996 Oct; 88(8):2871-7. PubMed ID: 8874183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment.
    Bautz F; Rafii S; Kanz L; Möhle R
    Exp Hematol; 2000 Jun; 28(6):700-6. PubMed ID: 10880756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment.
    Jedema I; Barge RM; Willemze R; Falkenburg JH
    Leukemia; 2003 Mar; 17(3):576-84. PubMed ID: 12646947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hematopoiesis regulation].
    Gronda MV; Bianchi de Di Risio CC
    Medicina (B Aires); 1993; 53(2):167-75. PubMed ID: 8295534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.
    Lee JW; Gersuk GM; Kiener PA; Beckham C; Ledbetter JA; Deeg HJ
    J Immunol; 1997 Oct; 159(7):3211-9. PubMed ID: 9317119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of granulocyte-colony stimulating factor on bone marrow-derived progenitor cells in murine cardiac transplantation.
    Rezai N; Deisher TA; Heine HL; Wang X; Corbel SY; Leung J; Kerjner A; Rossi FM; Podor TJ; McManus BM
    Cardiovasc Pathol; 2010; 19(1):36-47. PubMed ID: 19144547
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of cytokines following bone marrow transplantation: indications and controversies.
    Weinthal JA
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S10-4. PubMed ID: 8971400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.
    Lapidot T; Pflumio F; Doedens M; Murdoch B; Williams DE; Dick JE
    Science; 1992 Feb; 255(5048):1137-41. PubMed ID: 1372131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
    Luttmann W; Opfer A; Dauer E; Foerster M; Matthys H; Eibel H; Schulze-Osthoff K; Kroegel C; Virchow JC
    Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of macrophage- and granulocyte-colony stimulating factors on thymidylate synthase and thymidine kinase activity in rat hematopoietic cells.
    Kudo H; Suzuki S; Kuwa K; Nakayama T; Maemura M; Sakamoto S
    Haematologica; 1997; 82(2):187-8. PubMed ID: 9175325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased resistance to apoptosis by bone marrow CD34(+)progenitor cells from tumor-bearing mice.
    Young MR; Wright MA; Lathers DM; Messingham KA
    Int J Cancer; 1999 Aug; 82(4):609-15. PubMed ID: 10404079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement and clinical significance of circulating hematopoietic growth factor levels.
    Cebon J; Layton J
    Curr Opin Hematol; 1994 May; 1(3):228-34. PubMed ID: 9371287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells.
    Nagafuji K; Shibuya T; Harada M; Mizuno S; Takenaka K; Miyamoto T; Okamura T; Gondo H; Niho Y
    Blood; 1995 Aug; 86(3):883-9. PubMed ID: 7542501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic growth factors stimulate paraprotein isotype production by bone marrow mononuclear cells in an aggressive case of multiple myeloma.
    Säily M; Koistinen P; Laine S; Soppi E; Savolainen ER
    J Clin Lab Immunol; 1995; 46(1):41-7. PubMed ID: 9363591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis in myeloid progenitors by granulocyte-macrophage colony-stimulating factor.
    Alenzi FQ
    Br J Biomed Sci; 2004; 61(4):200-5. PubMed ID: 15649013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular control of hematopoiesis: from clonal development in culture to therapy in the clinic.
    Sachs L
    Int J Cell Cloning; 1992 Jul; 10(4):196-204. PubMed ID: 1645028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.